MR-angiography during spontaneous attacks of cluster headache: a case report.

abstract：OBJECTIVE:To determine the prevalence of migraine and episodic tension-type headache (ETTH) among university students as well as its impact on academic performance and quality of life. BACKGROUND:Headache is a very common symptom in clinical practice. The reduced capacities due to migraine can be profound, and more st...

journal_title：Headache

authors： Bigal ME,Bigal JM,Betti M,Bordini CA,Speciali JG

更新日期：2001-07-01 00:00:00

abstract：BACKGROUND:Though triptans are considered the standard of acute therapy for migraine attacks with headache-related disability, they are used by the minority of potentially eligible persons. Understanding the socio-demographic and headache features that predict triptan use may help to clarify barriers to optimal treatme...

journal_title：Headache

authors： Chu MK,Buse DC,Bigal ME,Serrano D,Lipton RB

更新日期：2012-02-01 00:00:00

abstract：OBJECTIVES/BACKGROUND:We herein investigated the role of polymorphisms in calcitonin gene-related peptide (CGRP)-related genes looking at the association of rs3781719 (T > C) in the calcitonin gene-related polypeptide-alpha (CALCA) gene and of rs3754701 (T > A) and rs7590387 (C > G) at the receptor activity modifying 1...

journal_title：Headache

authors： Cargnin S,Pautasso C,Viana M,Sances G,Mittino D,Cantello R,Tassorelli C,Nappi G,Terrazzino S

更新日期：2015-05-01 00:00:00

abstract：OBJECTIVE:To investigate variation in headache occurrence and characteristics over 1 year. BACKGROUND:Headache is a common condition which can affect the work, home, and social lives of sufferers, yet surprisingly little is known about how headache changes over time. METHODS:Postal survey to a random general populati...

journal_title：Headache

authors： Boardman HF,Thomas E,Millson DS,Croft PR

更新日期：2005-04-01 00:00:00

abstract：BACKGROUND:Zonisamide, a sulfonamide analog, is an antiepileptic drug with mechanisms of action similar to topiramate. Because of its pharmacodynamic and pharmacokinetics profiles, zonisamide is also potentially suitable for migraine prevention. METHODS:Tolerability and effectiveness of zonisamide for migraine prophyl...

journal_title：Headache

authors： Villani V,Ciuffoli A,Prosperini L,Sette G

更新日期：2011-02-01 00:00:00

abstract：:Botulinum toxin A used to treat headache evokes prominent placebo effects and it is likely that these effects are solely responsible for its apparent effectiveness. ...

journal_title：Headache

authors： Solomon S

更新日期：2011-06-01 00:00:00

abstract：PURPOSE:Migraine is an exclusively human chronic disorder with ictal manifestations characterized by a multifaceted clinical complexity pointing to a cerebral cortical involvement. The present review is aimed to cover the clinical, neuroimaging, and neurophysiological literature on the role of the cerebral cortex in mi...

journal_title：Headache

authors： Barbanti P,Brighina F,Egeo G,Di Stefano V,Silvestro M,Russo A

更新日期：2020-10-01 00:00:00

abstract：OBJECTIVE:To characterize adult patients with episodic migraine who achieved 100% response to galcanezumab treatment. BACKGROUND:Galcanezumab is a humanized monoclonal antibody that selectively binds to the calcitonin gene-related peptide (CGRP) and has demonstrated efficacy in reducing migraine headache days (MHD) in...

journal_title：Headache

authors： Rosen N,Pearlman E,Ruff D,Day K,Jim Nagy A

更新日期：2018-10-01 00:00:00

abstract：BACKGROUND:The protein s100b indicates astrocytal damage as well as dysfunction of the blood-brain barrier (BBB), and neuron-specific enolase (NSE) is regarded as a marker for neuronal cell loss. Recently, s100b was shown to be a potentially useful marker for migraine in children. In this study, we investigated the lev...

journal_title：Headache

authors： Teepker M,Munk K,Mylius V,Haag A,Möller JC,Oertel WH,Schepelmann K

更新日期：2009-02-01 00:00:00

abstract：:Interictal serum levels of serotonin and plasma and mononuclear cell concentrations of beta-endorphin were measured in 20 juvenile patients (13 suffering from migraine without aura and 7 from episodic tension-type headache) before and after 3 months of L-5-hydroxytryptophan treatment (5 mg/kg/day) and compared with a ...

journal_title：Headache

authors： Battistella PA,Bordin A,Cernetti R,Broetto S,Corrà S,Piva E,Plebani M

更新日期：1996-02-01 00:00:00

abstract：:A questionnaire study on headaches, using a door-to-door survey, was carried out in a representative sample of the general Greek population, including 1737 men and 1764 women, from 15 to 75 years of age. The parameters evaluated included age, sex, education, socioeconomic status, region of domicile, frequency of heada...

journal_title：Headache

authors： Mitsikostas DD,Tsaklakidou D,Athanasiadis N,Thomas A

更新日期：1996-03-01 00:00:00

abstract：BACKGROUND:MAP0004 is a novel orally inhaled formulation of dihydroergotamine mesylate (DHE) currently in development that has been clinically observed to provide rapid ( approximately 10 minutes) therapeutic levels of DHE but with lower rates of adverse effects (dizziness, nausea, and paresthesia) compared with intrav...

journal_title：Headache

authors： Cook RO,Shrewsbury SB,Ramadan NM

更新日期：2009-11-01 00:00:00

abstract：OBJECTIVE:To compare the efficacy of celecoxib for treatment of withdrawal headache vs prednisone in patients with medication overuse headache (MOH). METHODS:In this prospective, double-blind, parallel-group clinical trial, 97 consecutive subjects with MOH were randomized (simple randomization using computer-generated...

journal_title：Headache

authors： Taghdiri F,Togha M,Razeghi Jahromi S,Paknejad SM

更新日期：2015-01-01 00:00:00

abstract：:The presence of postural, myofascial, and mechanical abnormalities in patients with migraine, tension-type headache, or both headache diagnoses was compared to a headache-free control sample. Twenty-four control subjects were obtained from a convenience sampling and each was matched by age and sex to three patients wi...

journal_title：Headache

authors： Marcus DA,Scharff L,Mercer S,Turk DC

更新日期：1999-01-01 00:00:00

abstract：:The treatment of migraine was transformed in 1992 with the introduction of the first triptan-based therapy, subcutaneous (SC) sumatriptan. SC sumatriptan has high efficacy and a rapid onset of action compared with other available triptans and formulations presumably because of its short Tmax, high Cmax, and avoidance ...

journal_title：Headache

authors： Rothrock JF,Freitag FG,Farr SJ,Smith EF 3rd

更新日期：2013-09-01 00:00:00

abstract：OBJECTIVE:To evaluate the association between a serotonin (5-HT) transporter gene polymorphism and migraines in Koreans. BACKGROUND:The 5-HT metabolism is believed to play an important part in the pathophysiology of migraines, and a polymorphism of the serotonin transporter (5-HTT) promoter region might influence 5-HT...

journal_title：Headache

authors： Kim WK,Kim HS,Kim WJ,Lee KY,Park H,Kim CH,Kim SJ,Choi YC

更新日期：2005-09-01 00:00:00

abstract：:In a period of one year (1990) we selected 40 patients suffering from migraine. For an open randomized study there were 2 groups of patients: the first were treated with 10mg of flunarizine per day and the second with 3 mg per day. The patients were treated for 4 months consecutively. There were 11 drop outs (27.5%): ...

journal_title：Headache

authors： Bassi P,Brunati L,Rapuzzi B,Alberti E,Mangoni A

更新日期：1992-09-01 00:00:00

abstract：OBJECTIVE:To describe the outcome of a patient with refractory chronic paroxysmal hemicrania (CPH) to occipital nerve stimulation (ONS). BACKGROUND:CPH is a primary headache disorder exquisitely sensitive to indomethacin. In patients unable to tolerate indomethacin, the therapeutic options are limited. ONS is a promis...

journal_title：Headache

authors： Miller S,Lagrata S,Watkins L,Matharu M

更新日期：2017-11-01 00:00:00

abstract：:Although severe short-lasting headaches are rare, they can be considered disabling conditions with a major impact on the quality of life of patients. These headaches can divided broadly in to those associated with autonomic symptoms, so called trigeminal autonomic cephalgias (TACs), and those with few or no autonomic ...

journal_title：Headache

authors： May A

更新日期：2013-10-01 00:00:00

abstract：OBJECTIVE:To investigate differences in cortical thickness in patients with persistent post-traumatic headache (PPTH) relative to healthy controls and to interrogate whether cortical morphology relates to headache burden (headache frequency, years with post-traumatic headache, PTH) in patients with PPTH. BACKGROUND:PT...

journal_title：Headache

authors： Chong CD,Berisha V,Chiang CC,Ross K,Schwedt TJ

更新日期：2018-01-01 00:00:00

abstract：:A retrospective study was conducted on 1300 women suffering from migraine without aura referred to the Headache Centers of Parma and Pavia from 1984 to 1990. All the data concerning their reproductive life, and the modifications induced by it on the course of headache were obtained from record-charts. Migraine frequen...

journal_title：Headache

authors： Granella F,Sances G,Zanferrari C,Costa A,Martignoni E,Manzoni GC

更新日期：1993-07-01 00:00:00

abstract：BACKGROUND:Migraine is a common neurological disorder, ranked among the world's leading causes of years lived with disability by the World Health Organization. The burden of migraine is highest in women of reproductive age. METHODS:We characterized the prevalence, symptoms, and correlates of migraine and other headach...

journal_title：Headache

authors： Frederick IO,Qiu C,Enquobahrie DA,Aurora SK,Peterlin BL,Gelaye B,Williams MA

更新日期：2014-04-01 00:00:00

abstract：:Paroxysmal headaches often occur in benign headache disorders such as episodic cluster headache, chronic paroxysmal hemicrania (CPH) and episodic paroxysmal hemicrania. We report 2 patients with paroxysmal headaches occurring in association with cerebrovascular disease. The first patient had paroxysmal headaches from ...

journal_title：Headache

authors： Newman LC,Herskovitz S,Lipton RB,Solomon S

更新日期：1992-02-01 00:00:00

abstract：OBJECTIVE:To describe the pharmacokinetic and safety profiles of sumatriptan 85 mg formulated with RT Technology (RT) and naproxen sodium 500 mg in a fixed-dose combination tablet (sumatriptan/naproxen sodium) that targets both serotonergic dysmodulation and inflammation in migraine. METHODS:Six open-label, crossover ...

journal_title：Headache

authors： Haberer LJ,Walls CM,Lener SE,Taylor DR,McDonald SA

更新日期：2010-03-01 00:00:00

abstract：:Forty out-patients affected by chronic tension-type headache were selected according to the diagnostic criteria of International Headache Society (IHS) Headache Classification Committee. In a controlled trial patients received placebo for a four-week baseline period, then they were randomized in double-blind fashion t...

journal_title：Headache

authors： Manna V,Bolino F,Di Cicco L

更新日期：1994-01-01 00:00:00

abstract：:The prophylactic effect of flunarizine and metoprolol was studied in a multi-center randomized, double-blind trial of 149 patients with migraine with or without aura. After a 4-week placebo run-in period, patients were randomly allocated to treatment with flunarizine 10 mg daily or metoprolol 200 mg daily for 16 weeks...

journal_title：Headache

authors： Sørensen PS,Larsen BH,Rasmussen MJ,Kinge E,Iversen H,Alslev T,Nøhr P,Pedersen KK,Schrøder P,Lademann A

更新日期：1991-11-01 00:00:00

abstract：:To assess the burden of migraine, we compared the productivity and the perceived health of 991 migraine sufferers (IHS criteria), 1,004 other-headache sufferers, and 1,757 nonheadache sufferers randomly chosen among volunteers from employees of the French national gas and electricity company. The extent of absenteeism...

journal_title：Headache

authors： Michel P,Dartigues JF,Lindoulsi A,Henry P

更新日期：1997-02-01 00:00:00

abstract：:Calcitonin gene-related peptide (CGRP) is a ubiquitous neuropeptide found at the very centers of the migraine process, both centrally and peripherally. It has been under careful study for approximately 25 years. Several CGRP-receptor antagonists are being evaluated for acute treatment of episodic migraine. Three monoc...

journal_title：Headache

authors： Bigal ME,Walter S,Rapoport AM

更新日期：2013-09-01 00:00:00

abstract：:Headache centers have to deal with patients suffering from headache induced by chronic substance use which is a well-recognized complication of migraine treatment. The objective of this study was to compare psychiatric comorbidity between migraineurs with and without chronic substance use: 34 migrainous inpatients wit...

journal_title：Headache

authors： Radat F,Sakh D,Lutz G,el Amrani M,Ferreri M,Bousser MG

更新日期：1999-07-01 00:00:00

abstract：OBJECTIVES:In a randomized controlled trial extending over 6 months, we evaluated the effectiveness of acupuncture versus flunarizine in the prophylactic treatment of migraine without aura. METHODS:One hundred sixty women with migraines were randomly assigned to acupuncture treatment (group A, n = 80) or to an oral th...

journal_title：Headache

authors： Allais G,De Lorenzo C,Quirico PE,Airola G,Tolardo G,Mana O,Benedetto C

更新日期：2002-10-01 00:00:00